BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21445040)

  • 1. Preparation and use of HIV-1 infected primary CD4+ T-cells as target cells in natural killer cell cytotoxic assays.
    Davis ZB; Ward JP; Barker E
    J Vis Exp; 2011 Mar; (49):. PubMed ID: 21445040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals.
    Fogli M; Mavilio D; Brunetta E; Varchetta S; Ata K; Roby G; Kovacs C; Follmann D; Pende D; Ward J; Barker E; Marcenaro E; Moretta A; Fauci AS
    PLoS Pathog; 2008 Jul; 4(7):e1000101. PubMed ID: 18617991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes.
    Bonaparte MI; Barker E
    AIDS; 2003 Mar; 17(4):487-94. PubMed ID: 12598768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
    Tomescu C; Tebas P; Montaner LJ
    AIDS; 2017 Mar; 31(5):613-622. PubMed ID: 28225449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK cell lysis of HIV-1-infected autologous CD4 primary T cells: requirement for IFN-mediated NK activation by plasmacytoid dendritic cells.
    Tomescu C; Chehimi J; Maino VC; Montaner LJ
    J Immunol; 2007 Aug; 179(4):2097-104. PubMed ID: 17675468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-C and HLA-E reduce antibody-dependent natural killer cell-mediated cytotoxicity of HIV-infected primary T cell blasts.
    Ward JP; Bonaparte MI; Barker E
    AIDS; 2004 Sep; 18(13):1769-79. PubMed ID: 15316337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells.
    Kiani Z; Dupuy FP; Bruneau J; Lebouché B; Retière C; Geraghty DE; Bernard NF
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the antiviral capacity of primary natural killer cells by optimized in vitro quantification of HIV-1 replication.
    He X; Simoneau CR; Granoff ME; Lunemann S; Dugast AS; Shao Y; Altfeld M; Körner C
    J Immunol Methods; 2016 Jul; 434():53-60. PubMed ID: 27094484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.
    Fausther-Bovendo H; Sol-Foulon N; Candotti D; Agut H; Schwartz O; Debré P; Vieillard V
    AIDS; 2009 Jun; 23(9):1077-87. PubMed ID: 19424050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal
    Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
    Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
    J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human natural killer cells in asymptomatic human immunodeficiency virus-1 infection.
    Hultström AL; Hejdeman B; Leandersson AC; Bratt G; Carbone E; Wahren B
    Intervirology; 2000; 43(4-6):294-301. PubMed ID: 11251385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells.
    Davis ZB; Sowrirajan B; Cogswell A; Ward JP; Planelles V; Barker E
    AIDS Res Hum Retroviruses; 2017 Feb; 33(2):93-100. PubMed ID: 27296670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redirection of Cord Blood T Cells and Natural Killer Cells for Elimination of Autologous HIV-1-Infected Target Cells Using Bispecific DART® Molecules.
    Pollara J; Edwards RW; Jha S; Lam CK; Liu L; Diedrich G; Nordstrom JL; Huffman T; Pickeral JA; Denny TN; Permar SR; Ferrari G
    Front Immunol; 2020; 11():713. PubMed ID: 32373131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysis of HIV-1-infected autologous CD4+ primary T cells by interferon-alpha-activated NK cells requires NKp46 and NKG2D.
    Tomescu C; Mavilio D; Montaner LJ
    AIDS; 2015 Sep; 29(14):1767-73. PubMed ID: 26372382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficiency of HIV-1-infected T cell killing by NK cells, monocytes and neutrophils.
    Smalls-Mantey A; Connors M; Sattentau QJ
    PLoS One; 2013; 8(9):e74858. PubMed ID: 24040353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-infected macrophages resist efficient NK cell-mediated killing while preserving inflammatory cytokine responses.
    Clayton KL; Mylvaganam G; Villasmil-Ocando A; Stuart H; Maus MV; Rashidian M; Ploegh HL; Walker BD
    Cell Host Microbe; 2021 Mar; 29(3):435-447.e9. PubMed ID: 33571449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective killing activity against gp120/41-expressing human erythroleukaemic K562 cell line by monocytes and natural killer cells from HIV-infected individuals.
    Ahmad A; Menezes J
    AIDS; 1996 Feb; 10(2):143-9. PubMed ID: 8838701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response.
    Ward J; Davis Z; DeHart J; Zimmerman E; Bosque A; Brunetta E; Mavilio D; Planelles V; Barker E
    PLoS Pathog; 2009 Oct; 5(10):e1000613. PubMed ID: 19798433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms.
    Ni Z; Knorr DA; Clouser CL; Hexum MK; Southern P; Mansky LM; Park IH; Kaufman DS
    J Virol; 2011 Jan; 85(1):43-50. PubMed ID: 20962093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.